BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33596489)

  • 1. In vitro and in vivo antiplasmodial activity of novel quinoline derivative compounds by molecular hybridization.
    Marinho JA; Martins Guimarães DS; Glanzmann N; de Almeida Pimentel G; Karine da Costa Nunes I; Gualberto Pereira HM; Navarro M; de Pilla Varotti F; David da Silva A; Abramo C
    Eur J Med Chem; 2021 Apr; 215():113271. PubMed ID: 33596489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple quinoline salt derivative is active in vitro against Plasmodiumfalciparum asexual blood stages and inhibits the development of cerebral malaria in murine model.
    Bezerra Bellei JC; Glanzmann N; Carpinter BA; Renhe DC; Marques CB; Azevedo MR; Barreto LM; Rocha VN; Karine da Costa Nunes I; Gualberto Pereira HM; Coimbra ES; Ferraz Coelho EA; David da Silva A; de Pilla Varotti F; Gorza Scopel KK
    Chem Biol Interact; 2022 Mar; 355():109848. PubMed ID: 35149084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantiomerically pure amino-alcohol quinolines: in vitro anti-malarial activity in combination with dihydroartemisinin, cytotoxicity and in vivo efficacy in a Plasmodium berghei mouse model.
    Mullié C; Taudon N; Degrouas C; Jonet A; Pascual A; Agnamey P; Sonnet P
    Malar J; 2014 Oct; 13():407. PubMed ID: 25319003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of the antiplasmodial activity of novel indeno[2,1-c]quinoline derivatives.
    Barteselli A; Parapini S; Basilico N; Mommo D; Sparatore A
    Bioorg Med Chem; 2014 Nov; 22(21):5757-65. PubMed ID: 25311562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline.
    Davioud-Charvet E; Delarue S; Biot C; Schwöbel B; Boehme CC; Müssigbrodt A; Maes L; Sergheraert C; Grellier P; Schirmer RH; Becker K
    J Med Chem; 2001 Nov; 44(24):4268-76. PubMed ID: 11708927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N10,N11-di-alkylamine indolo[3,2-b]quinolines as hemozoin inhibitors: design, synthesis and antiplasmodial activity.
    Figueiras M; Coelho L; Wicht KJ; Santos SA; Lavrado J; Gut J; Rosenthal PJ; Nogueira F; Egan TJ; Moreira R; Paulo A
    Bioorg Med Chem; 2015 Apr; 23(7):1530-9. PubMed ID: 25725608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.
    Warhurst DC; Craig JC; Adagu IS; Guy RK; Madrid PB; Fivelman QL
    Biochem Pharmacol; 2007 Jun; 73(12):1910-26. PubMed ID: 17466277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships for new 6-fluoroquinoline derivatives with antiplasmodial activity.
    Hochegger P; Faist J; Seebacher W; Saf R; Mäser P; Kaiser M; Weis R
    Bioorg Med Chem; 2019 May; 27(10):2052-2065. PubMed ID: 30962114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives.
    Jonckers TH; van Miert S; Cimanga K; Bailly C; Colson P; De Pauw-Gillet MC; van den Heuvel H; Claeys M; Lemière F; Esmans EL; Rozenski J; Quirijnen L; Maes L; Dommisse R; Lemière GL; Vlietinck A; Pieters L
    J Med Chem; 2002 Aug; 45(16):3497-508. PubMed ID: 12139461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antimalarial activity of carbamate and amide derivatives of 4-anilinoquinoline.
    Delarue-Cochin S; Grellier P; Maes L; Mouray E; Sergheraert C; Melnyk P
    Eur J Med Chem; 2008 Oct; 43(10):2045-55. PubMed ID: 18226428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplasmodial activity and cytotoxicity of bis-, tris-, and tetraquinolines with linear or cyclic amino linkers.
    Girault S; Grellier P; Berecibar A; Maes L; Lemière P; Mouray E; Davioud-Charvet E; Sergheraert C
    J Med Chem; 2001 May; 44(11):1658-65. PubMed ID: 11356101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, β-haematin inhibition, and in vitro antimalarial testing of isocryptolepine analogues: SAR study of indolo[3,2-c]quinolines with various substituents at C2, C6, and N11.
    Wang N; Wicht KJ; Imai K; Wang MQ; Anh Ngoc T; Kiguchi R; Kaiser M; Egan TJ; Inokuchi T
    Bioorg Med Chem; 2014 May; 22(9):2629-42. PubMed ID: 24721829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Antiplasmodial Potential of C2 and C8 Modified Quinolines: in vitro and in silico Study.
    Kumar R; Sharma R; Kumar I; Upadhyay P; Dhiman AK; Kumar R; Kumar R; Purohit R; Sahal D; Sharma U
    Med Chem; 2019; 15(7):790-800. PubMed ID: 30324888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro antiplasmodial activity of ferrocenyl aminoquinoline derivatives.
    Mwande Maguene G; Lekana-Douki JB; Mouray E; Bousquet T; Grellier P; Pellegrini S; Toure Ndouo FS; Lebibi J; Pélinski L
    Eur J Med Chem; 2015 Jan; 90():519-25. PubMed ID: 25486423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New compounds hybrids 1h-1,2,3-triazole-quinoline against Plasmodium falciparum.
    Boechat N; Ferreira Mde L; Pinheiro LC; Jesus AM; Leite MM; Júnior CC; Aguiar AC; de Andrade IM; Krettli AU
    Chem Biol Drug Des; 2014 Sep; 84(3):325-32. PubMed ID: 24803084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolin-4(1H)-imines are potent antiplasmodial drugs targeting the liver stage of malaria.
    Rodrigues T; da Cruz FP; Lafuente-Monasterio MJ; Gonçalves D; Ressurreição AS; Sitoe AR; Bronze MR; Gut J; Schneider G; Mota MM; Rosenthal PJ; Prudêncio M; Gamo FJ; Lopes F; Moreira R
    J Med Chem; 2013 Jun; 56(11):4811-5. PubMed ID: 23701465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplasmodial activity of [(aryl)arylsulfanylmethyl]Pyridine.
    Kumar S; Das SK; Dey S; Maity P; Guha M; Choubey V; Panda G; Bandyopadhyay U
    Antimicrob Agents Chemother; 2008 Feb; 52(2):705-15. PubMed ID: 18025110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and in vitro antiplasmodial activity of some bisquinolines against chloroquine-resistant strain.
    Kondaparla S; Agarwal P; Srivastava K; Puri SK; Katti SB
    Chem Biol Drug Des; 2017 Jun; 89(6):901-906. PubMed ID: 27896925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplasmodial activity of targeted zinc(II)-dipicolylamine complexes.
    Rice DR; de Lourdes Betancourt Mendiola M; Murillo-Solano C; Checkley LA; Ferdig MT; Pizarro JC; Smith BD
    Bioorg Med Chem; 2017 May; 25(10):2754-2760. PubMed ID: 28377170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.